arterolane

Small moleculeexperimental

Arterolane, also known as OZ277 or RBx 11160, is an antimalarial compound marketed by Ranbaxy Laboratories. It was discovered by US and European scientists coordinated by the Medicines for Malaria Venture (MMV). Its molecular structure is uncommon for pharmacological compounds in that it has both an ozonide (trioxolane) group and an adamantane substituent. — Wikipedia

Clinical trial activity

3 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0

Earliest trial started Jun 1, 2006 (NCT00362050)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • arterolane
  • arterolane
  • arterolane
  • arterolane
  • arterolane
  • arterolane maleate
  • oz277
  • oz 277
  • oz 277
  • oz-277
  • oz277 cpd
  • rbx11160
  • rbx11160
  • rbx 11160
  • rbx-11160

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03452475Phase 3Mar 10, 2018Mahidol University, University of Oxford
NCT02461186Phase 2/Phase 3 (Phase 3)Jun 1, 2015Department of Medical Research, Lower Myanmar, Mahidol University, University of Oxford
NCT00362050Phase 2Jun 1, 2006District Hospital Bagamoyo, Dar es Salaam, Tanzania, Kivunge Public Health Care Center, Zanzibar, Tanzania, Mahidol University, Malaria Research Center, Rourkela, India, Medicines for Malaria Venture, Ranbaxy, University of Basel
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Mahidol UniversityAcademic/Hospital3022006
University of OxfordAcademic/Hospital2212015
Department of Medical Research, Lower MyanmarAcademic/Hospital1012015
District Hospital Bagamoyo, Dar es Salaam, TanzaniaAcademic/Hospital1012006
Kivunge Public Health Care Center, Zanzibar, TanzaniaAcademic/Hospital1012006
Malaria Research Center, Rourkela, IndiaAcademic/Hospital1012006
Medicines for Malaria VentureAcademic/Hospital1112006
RanbaxyFor profit1012006
University of BaselAcademic/Hospital1012006
9 organizations
Page 1 / 1